NKB Biopharma Private Limited is an Indian pharmaceutical chemistry startup developing ultra-high purity active pharmaceutical ingredients (APIs) and excipients for the world’s most regulated pharmaceutical markets including Europe, the United States, and Russia.
Four expertly formulated products spanning critical therapeutic areas, each developed with patient wellbeing at the center.
It acts as an organic source of phosphorus, supporting cellular metabolism and aiding in reversing hypophosphatemia.
Learn More →It improves glycemic control when combined with diet and exercise, usually taken once daily. Common side effects include headache and nausea.
Learn More →It lowers blood sugar by causing the kidneys to remove excess glucose through urine.
Learn More →It works by directly inhibiting factor Xa, a clotting factor, and is commonly used for patients with nonvalvular atrial fibrillation or after hip/knee replacement surgery.
Learn More →NKB Pharma distributes life-changing medicines across three continents, partnering with healthcare systems to improve patient outcomes in both developed and emerging markets.
Guided by science and driven by purpose, we uphold three pillars that define every decision we make.
State-of-the-art R&D labs driving continuous innovation in evidence-based pharmaceutical solutions.
ISO-certified manufacturing with rigorous clinical testing to ensure every product meets global safety standards.
Committed to eco-friendly production processes and responsible sourcing for a healthier planet.
